FABP4 and myocardial infarction: Thus, our research may uncover FABP4 as a novel regulator of cardiomyocyte apoptosis associated with MI pathogenesis, and provide a molecular basis for applying FABP4 activity inhibitor in the intervention of cardiomyocyte loss during MI, such as BMS309403 (Figure 6).